Skip Navigation



NDT Advance Access published online on April 15, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn179
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/10/3126    most recent
gfn179v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kitagawa, W.
Right arrow Articles by Sugiyama, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitagawa, W.
Right arrow Articles by Sugiyama, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease

Wataru Kitagawa1, Hirokazu Imai1, Atsushi Komatsuda1, Nobuki Maki1, Hideki Wakui2, Yoshiyuki Hiki3 and Satoshi Sugiyama3

1 Department of Internal Medicine, Division of Nephrology and Rheumatology, Aichi Medical University School of Medicine, Aichi 480-1195 2 Third Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita City, Akita 010-8543 3 Department of Medicine, Division of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan

Correspondence and offprint requests to: Hirokazu Imai, Nephrology and Rheumatology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan. Tel: +81-561-62-3311; Fax: +81-561-62-6694; E-mail: imaihiro{at}aichi-med-u.ac.jp



  Abstract

Purpose. We aimed to clarify the relationship between HLA-DRB1*1501 and anti-glomerular basement membrane (GBM) antibody-mediated disease in Japanese patients.

Materials and methods. Samples were collected from 16 anti-GBM antibody-positive patients who were admitted to our department or related hospitals from December 1990 to October 2005. We analysed clinical and laboratory data, kidney biopsy findings, and the HLA-DR phenotypes and HLA-DRB1 alleles of the patients.

Results. Among the 16 patients, 15 had HLA-DR15 [the phenotype frequency (PF) was 93.8%], 7 were positive for DR4 (the PF was 43.8%) and 5 were positive for DR9 (the PF was 31.3%). The allele frequency of HLA-DRB1*1501 was 46.4% (13/28), which was significantly different from Japanese controls (11.6%) (P < 0.001). In contrast, the frequency of HLA-DRB1*1502 was not different from controls (0/28). The odds ratio of HLA-DRB1*1501 in these patients was 6.4 (95% CI: 2.4–16.5).

Conclusion. The present study demonstrated that Japanese patients with anti-GBM antibody-mediated disease are very likely to carry the HLA-DRB1*1501 but not the HLA-DRB1*1502 allele.

Keywords: anti-glomerular basement membrane antibody; Goodpasture's disease; HLA-DR15; HLA-DRB1*1501

Received for publication: 24. 1.07
Accepted in revised form: 6. 3.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
X.-j. Zhou, J.-c. LV, L. Yu, Z. Cui, J. Zhao, R. Yang, J. Han, P. Hou, M.-h. Zhao, and H. Zhang
FCGR2B gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese
Nephrol. Dial. Transplant., July 29, 2009; (2009) gfp374v1.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.